Farmaci e contraffazione

Selezione di pubblicazioni internazionali

• Shakoor O, Taylor RB, Behrens RH (1997) Assessment of the incidence of substandard drugs in developing countries. Trop. Med. Int. Health 2: 839-845
  
  
• Laserson KF, Kenyon AS, Kenyon TA, Layloff T, Binkin NJ (2001) Substandard tuberculosis drugs on the global market and their simple detection. Int. J. Tuberc. Lung Dis. 5: 448-454
  
  
• Ahmad K (2004) Antidepressant are sold as antiretrovirals in DR Congo The Lancet 363: 713.
  
  
• Dondorp AM, Mayxay M, Van Damme W, Smithuis FM, Yeung S at al. (2004) Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop. Med. Int. Health 9:1241-1246.
  
  
• Rudolf PM, Bernstein IBG (2004) Counterfeit Drugs. N. Engl. J. Med. 350 (14): 1384-1386
  
  
• Cockburn R, Newton PN, Kyeremateng Agyarko E, Akunyili D, White NJ (2005) The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLoS Med 2: 302-308
  
  
• Akunyili D (2005) Counterfeit and substandard drugs, Nigeria’s experience: implications, challenges, actions and recommendations. Meeting for key interest groups on health organized by Washington DC, 10th-11th March 2005 (Source: World Bank).
  
  
• Aldhous P (2005) Counterfeit pharmaceuticals: Murder by medicine. (http://www.nature.com/nature/journal/v434/n7030/full/434132a.html) Nature 434: 132-136.
  
  
• Newton PN, Green MD, Fernandez FM, Day NPJ, White NJ (2006) Counterfeit anti-infective drugs. The Lancet infectious disease 6: 602-613.